Video Library

In this session, leading experts on graft-versus-host disease (GVHD), a common complication after a bone marrow/stem cell transplant, respond to questions about who is at risk of developing GVHD, symptoms of GVHD, and how to manage both the physical and emotional problems associated with GVHD and its treatment.

This session features leading experts in CAR T-cell therapy for lymphoma and multiple myeloma, and a social worker who helps CAR T patients manage psychosocial and financial challenges during and after treatment. They discuss current CAR T therapies available for myeloma and lymphoma patients, side effects and outcomes after CAR T-cell therapy, and new CAR T products on the horizon.

This presentation provides an overview of various long-term effects that may occur after an autologous stem cell transplant, and provides strategies and advice for how these effects might be managed.

Bone marrow/stem cell transplant survivors need a comprehensive plan for long-term follow-up care. This presentation discusses the challenges survivors face in accessing this care and strategies to overcome these challenges.

This presentation discusses what a clinical trial is, why they are necessary, the phases of a clinical research trials, how they are reviewed to ensure patient safety, the process involved in participating in a clinical trial, and where one can go to receive further information about clinical trials. 

This presentation outlines the importance of long-term follow-up care after a bone marrow/stem cell transplant using donor cells (allogeneic transplant) focused on supportive care for side effects post-transplant, identifying new health issues early, and providing resources and guidance to ensure the patient is experiencing their optimal quality of life after treatment.

Maintenance therapy is now standard of care treatment in newly diagnosed patients with multiple myeloma. This presentation describes what maintenance therapy is, current medications being utilized for maintenance, and what current clinical trials are hoping to reveal.

This presentation outlines what an autoimmune disease is, current treatment options for these diseases, how autologous transplants are effective in treating specific autoimmune diseases, and the short- and long-term side effects of stem cell transplantation.

Older age used to be a prohibitive factor for receiving a bone marrow/stem cell transplant, but this is changing. This presentation reviews the evidence that some older patients can be good candidates for transplant as well as CAR T-cell therapy and how to assess their risks.

This presentation gives a thorough description of the CAR T-cell therapy process for B-cell acute lymphoblastic leukemia (B-cell ALL), and discusses short- and long-term side effects and toxicities, expected outcomes, and ongoing research related to this therapy.

CAR T cell therapy has become an increasingly common treatment for patients with diffuse large B-cell lymphoma, (DLBCL), follicular lymphoma (FL), and mantle cell lymphoma. This presentation discusses how it works, who is a good candidates for CAR T-cell therapy, and the risks and benefits of the treatment.

This presentation discusses CAR T-cell therapy for multiple myeloma. It explains what CAR T-cell therapy is, the process, and what clinical trials are indicating in regards to short- and long-term side effects, patient outcomes, and quality of life.